# Trial of Pirfenidone to Prevent Progression in Chronic Kidney Disease

Study · id `cardio:ct-nct04258397` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT04258397](<https://clinicaltrials.gov/study/NCT04258397>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT04258397

Browse, organ or system: Kidneys  
Browse, condition area: Kidney connections  

## In plain language

A phase 2 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 200 participants.

## Technical summary

Registry record NCT04258397. Randomized; triple masking; primary purpose other. Start 2020-10-26 (actual); primary completion 2024-05 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; triple masking; primary purpose other
- Phase: Phase 2
- Enrolled: 200 participants (planned count; ClinicalTrials.gov record NCT04258397, source copy `cardio:ctgov-nct04258397-2022-04-27`, retrieved 2026-10-26)
- Started: 2020-10-26 (actual) (ClinicalTrials.gov record NCT04258397, source copy `cardio:ctgov-nct04258397-2022-04-27`, retrieved 2026-10-26)
- Primary completion: 2024-05 (anticipated) (ClinicalTrials.gov record NCT04258397, source copy `cardio:ctgov-nct04258397-2022-04-27`, retrieved 2026-10-26)
- Completion: 2024-12 (anticipated) (ClinicalTrials.gov record NCT04258397, source copy `cardio:ctgov-nct04258397-2022-04-27`, retrieved 2026-10-26)
- Countries: United States (ClinicalTrials.gov record NCT04258397, source copy `cardio:ctgov-nct04258397-2022-04-27`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct04258397-2022-04-27`, retrieved 2026-10-26)

## The registry's words

- Brief title: Trial of Pirfenidone to Prevent Progression in Chronic Kidney Disease
- Acronym: TOP-CKD
- Condition: Chronic Kidney Disease
- Intervention (Drug): Pirfenidone
- Intervention (Drug): matching placebo
- Lead sponsor: Veterans Medical Research Foundation
- Lead sponsor class: OTHER
- Collaborator: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
- Collaborator class: NIH
- Collaborator: San Diego Veterans Healthcare System
- Collaborator class: FED
- Collaborator: University of California, San Diego
- Collaborator class: OTHER
- Collaborator: University of California, San Francisco
- Collaborator class: OTHER
- Collaborator: Genentech, Inc.
- Collaborator class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Chronic kidney disease (CKD) (`cardio:chronic-kidney-disease`)
- Registry lists this organization as a collaborator: National Institute of Diabetes and Digestive and Kidney Diseases (`cardio:niddk`)
- Registry lists this organization as a collaborator: University of California, San Diego (`cardio:org-university-of-california-san-diego`)
- Registry lists this organization as a collaborator: University of California, San Francisco (`cardio:org-university-of-california-san-francisco`)
- Registry lists this organization as a collaborator: Genentech, Inc. (`cardio:org-genentech-inc`)

## Provenance

Content hash: 9357a94ffb32deeef9d8e50c8505220d2c246f74af863ac2b70a432ec61220b5
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
